论文部分内容阅读
目的观察不同剂量的氨溴索静脉滴注治疗脑卒中后肺炎的临床疗效。方法选取60例脑卒中后肺炎患者,在常规治疗的基础上,分为两组,研究组30例和对照组30例,研究组采用氨溴索60mg+生理盐水100ml静脉滴注,连用7d,4次/d,对照组采用氨溴索30mg+生理盐水100ml静脉滴注,连用7d,2次/d。通过记录两组患者治疗前后临床肺部感染评分、C反应蛋白,比较两组治疗的效果。结果研究组肺部感染好转率明显高于对照组(P<0.05),肺部感染计分明显低于对照组,C反应蛋白明显低于对照组。结论不同剂量氨溴索静脉滴注治疗脑卒中后肺炎的效果不同,剂量大者治疗效果明显优于低剂量者。
Objective To observe the clinical efficacy of different doses of ambroxol intravenous infusion in the treatment of post-stroke pneumonia. Methods Sixty patients with post-stroke pneumonia were selected and divided into two groups on the basis of routine treatment: 30 in study group and 30 in control group. The study group was given intravenous infusion of ambroxol 60mg + Times / d, the control group with ambroxol 30mg + saline 100ml intravenous infusion, once every 7d, 2 times / d. By recording the clinical lung infection scores and C-reactive protein in two groups before and after treatment, the effect of the two groups was compared. Results The lung infection rate in the study group was significantly higher than that in the control group (P <0.05). The lung infection score was significantly lower than that in the control group, and C-reactive protein was significantly lower than that in the control group. Conclusion Different dosages of ambroxol intravenous drip in the treatment of post-stroke pneumonia have different effects, the larger dose of treatment was significantly better than the low dose.